Pfizer-BioNTech seek EU agency nod for COVID vaccines for kids 5-11

Published On 2021-10-17 04:30 GMT | Update On 2021-10-19 05:19 GMT

Berlin : Pharmaceutical company Pfizer and biotechnology company BioNTech informed they have requested to have their coronavirus vaccine licensed for children ages 5 to 11 across the European Union. If EU regulators agree, it would be the first opportunity for younger children in Europe to get immunized against COVID-19.

Pfizer and BioNTech said they submitted data to the European Medicines Agency (EMA), including late-stage results from a study testing their COVID-19 vaccine in more than 2,200 children ages 6 months to 11 years. The children received a lower dose than what's normally given to adults.

The companies said in a statement that the results showed a "strong immune response" in the children and that the vaccine was also found to be safe.

There are currently no COVID-19 vaccines licensed for use in children younger than 12 in Europe or North America; the ones made by Pfizer-BioNTech and Moderna are authorized for children 12 and older in the European Union.

Earlier this month, Pfizer and BioNTech asked the U.S. Food and Drug Administration (USFDA) to greenlight their vaccine for children ages 5 to 11.

Expanding vaccine availability to roughly 28 million more U.S. children was seen as another milestone in the fight against the virus and comes amid an alarming rise in serious infections in youngsters because of the extra-contagious delta variant.

In the United States, COVID-19 has killed at least 520 children so far, according to the American Academy of Pediatrics.

With much of Europe's adult population already immunized, many countries are seeing increasing outbreaks of the disease in children while schools are mostly open and operating with sometimes patchy guidance on mask-wearing and social distancing.

The World Health Organization has said that vaccinating children was not a priority because they are far less likely to develop serious disease or to die of COVID-19. The health agency has repeatedly urged rich countries to share their doses with poor countries instead of expanding domestic eligibility so the world's vulnerable populations can be immunized.

Read also: Pfizer COVID vaccine for kids may not be available until November

Article Source : AP

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Pfizer-BioNTech seek EU agency nod for COVID vaccines for kids 5-11

Similar News

CDSCO Criminal Prosecution Against IndiaMART Put on Hold by Delhi HC Till Sept 17

Novo Nordisk Gets CDSCO Panel Nod for Rybelsus Label Update, Aligned with EMA

NPPA Updates Ceiling Price Applicability for Ringer Lactate Non-Glass Packs, Details

CDSCO Eases Rules for Biopharma Research, Will Accept Lab Biosafety Committee Approvals

41 Pharmacies in Delhi Caught Illegally Selling Abortion Pills Mifepristone, Misoprostol

Visakhapatnam Pharma Plant Gas Leak Claims Chemist's Life, CITU Alleges Negligence

Torrent Pharma to acquire 26% stake in Torrent Urja 27 for captive renewable power project

Sanofi Tzield approved in China for adult, pediatric patients with stage 2 type 1 diabetes